Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

S-8

SEC Filing Details

Document Details

Form
Filing Date
Jul 2, 2018
Document Date
Jul 2, 2018
Form Description
Securities offered to employees pursuant to employee benefit plans
Filing Group
Registration Statements
Company
Stemline Therapeutics
Issuer
STEMLINE THERAPEUTICS INC


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved